• Biomolecules & Therapeutics
• /
• 제15권1호
• /
• pp.1-6
• /
• 2007

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of sup-porting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.

• 한국임상약학회지
• /
• 제18권1호
• /
• pp.18-27
• /
• 2008

This study investigated social relief schemes for serious adverse drug reactions in foreign countries and deduced lessons and implications for Korea to implement the scheme. A social relief scheme for serious adverse drug reactions provides reliefs for diseases and such health effects as disabilities or deaths that were caused by adverse reactions to pharmaceuticals prescribed at hospitals and clinics as well as those purchased at pharmacies notwithstanding their proper use. The US and the UK do not have specific relief schemes for adverse drug reactions but apply rules of strict liability or negligence. New Zealand and Nordic countries provide no-fault compensation schemes for health effects or injuries caused by medical treatments or medicinal products. Japan and Taiwan have operated the schemes since 1980 and 2000, respectively. In designing the scheme in Korea, we suggested that cases eligible for relief be confined to serious adverse reactions such as death or disability and then extended to diseases. It is desirable to encourage the reporting system of adverse drug reactions and quality use of medicines for the relief scheme to work efficiently.

• 한국약용작물학회:학술대회논문집
• /
• 한국약용작물학회 2006년도 Proceedings of The Convention of The Korean Society of Applied Pharmacology
• /
• pp.23-39
• /
• 2006

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of supporting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.

• 한국의료질향상학회지
• /
• 제12권2호
• /
• pp.93-112
• /
• 2006

This study reviewed published studies on interventions used by hospitals, health insurance programs, or governments to improve use of medicines in foreign countries. Interventions to improve use of medicines are classified into two categories: 1) information strategies-dissemination of educational materials, group education, one-to-one educational outreach, drug utilization review, and feedback; 2) managerial strategies- formularies, prior authorization, and financial incentives. Dissemination of educational materials, which is a common intervention, was unsuccessful in changing physicians' prescribing behaviors. Problem-based small group education was more likely to change behaviors than didactic large group education. One-to-one educational outreach(academic detailing) was among the most effective strategies used to change prescribing behaviors. Prospective drug utilization review (DUR) program was more successful in improving use of medicines than retrospective DUR program. Feedback intervention has been reported to be ineffective to change behaviors. Formularies are frequently used to control medication use by most health insurance programs. Financial incentives provide physicians economic incentives according to appropriateness of prescribing. However, few published studies have assessed the efficacy of formularies or financial incentives. Prior authorization requires physicians to get authorization from health insurers before prescribing a certain group of drugs which is usually of high costs or risk. There is no magic bullet for quality use of medicines. Multifaceted interventions that help to predispose, enable, and reinforce desired behaviors are more likely to be successful.

• 약학회지
• /
• 제54권4호
• /
• pp.282-287
• /
• 2010

Appropriate drug information is essential in pharmaceutical care practice. In recent years, educating patients with their prescription and drug therapy is becoming an increasingly important aspect of health care. Appropriate drug information has been shown to improve patients' adherence to their medication and the results of pharmacotherapy. The purpose of this study was to study patients' sources of drug information and their preferences in Korea. This study was a 11-questionnaire survey conducted from February 8, 2010 to February 25, 2010. Major sources of drug information used by respondents, proportions of respondents who received drug information on administration, dosage, indication, or warnings and precautions, sources of drug information which patients prefer, and the reasons of their preferences were studied. Of the 303 respondents, the most common sources of drug information were pharmacists (29.7%), doctors (23.8%), and the Internet (17.2%). There were significant differences according to sources of drug information in proportions of respondents who received drug information on administration, dosage, indication, or warnings and precautions. Patients preferred pharmacists as a drug information source the most (38.9%), and the reasons were reliability (72.0%) and easy to use (28.0%). Based on the results of this study, further studies should be conducted to establish the best way to provide appropriate drug information for patients and improve the results of pharmacotherapy.

• 대한화장품학회:학술대회논문집
• /
• 대한화장품학회 2003년도 IFSCC Conference Proceeding Book II
• /
• pp.528-528
• /
• 2003

The present study was undertaken to develop the in vitro sun protection factor(SPF) test method having good correlation with in vivo method using human. 8% homomentyl salicylate, P3 reference standard and commercially available sunscreen products were measured by the in vitro method using SPF 290S analyzer, and the SPFs were compared with the SPFs measured by in vivo test method. In vitro SPFs of 8% HMS and P3 reference standard were 4.59 $\pm$ 0.12 and 14.94 $\pm$ 0.83. There are good correspondence, correlation coefficients were 0.9506 and 0.9769 respectively, between the in vitro and in vivo SPFs for the sunscreen creams and lotions. Correlation coefficients of makeup base/liquid foundation, lotion labled with "shake before use" and compact powder were 0.8812, 0.8632 and 0.5984 respectively. The optimum mixture ratio of compact powder and cream base represents 1:0.8. These results suggest that the in vitro SPF test method will be able to be used as an alternative method for in vivo SPF in case of lotion and cream.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제1권1호
• /
• pp.130-147
• /
• 1990

본 연구는 우리나라 청소년들 중 음주, 흡연, 본드흡입 등을 위주로 한 약물사용 청소년들에게 특징적으로 나타나는 변인들이 무엇인지를 밝히고, 이러한 변인들과 청소년의 약물사용과의 관계는 어떻게 설명되어질 수 있는지를 고찰해 보고자 하였다 서울지역 고등학교 1, 2학년에 재학중인 남자 465명과 여자 433명, 총 898명을 대상으로 자종 약물의 사용여부와 학업성적, 비행경험, 약물사용 동료수, 지각된 약물의 입수용이도, 가족의 훈육도, 부모 외 일반적인 음주와 흡연에 대한 태도 및 자아개념 수준과 정신건강 수준을 조사하였다. 전체 표본을 사용하고 있는 약물의 수에 따라 남자 6집단, 여자 5집단으로 구분하여 위에 열거한 변인들이 집단에 따라 차이가 있는지를 검증하였다. 결과 우리나라 청소년들이 가장 많이 사용하는 약물은 담배와 술이었으며, 남자의 경우는 환각물질을, 여자의 경우는 진통진정제를 사용하는 이들이 상당수 있었다. 남자와 여자에게서 각 약물의 사용율을 전반적으로 차이가 있었으나, 그럼에도 불구하고 각 집단에 따른 변인들의 차이검증 결과는 크게 다르지 않았다. 일반적으로 여러종류의 약물을 사용하는 집단이 그렇지 않은 집단에 비해 학업성적이 낮고 비행경험 및 약물사용동료가 많았다. 또한 전자가 후자에 비해 비교적 낮은 정신건강수준과 자아개념수준을 나타냈다. 한편 차이를 나타냈던 여러변인들 중에서 무사용집단과 가장 많은 수의 약물을 사용하는 집단을 변별하는 두드러진 변인은 일반적인 적대감과 비행경험인 것으로 판별분석 결과 나타났다. 많은 종류의 약물을 사용하는 학생일수록 일상생활의 여러 측면에서 부적응적인 양상을 나타낸다는 본 연구의 결과는 약물의 사용은 공통적인 여러변인들과 관계가 있으며 많은 약물관련변인을 지닌 사람이 더 많은 약물을 사용하게 된다는 공통위험요인이론에 부합되는 것이라고 할 수 있다.

• 대한불안의학회지
• /
• 제1권1호
• /
• pp.37-42
• /
• 2005

Benzodiazepines are widely used for a variety of conditions in psychiatric field. In this article, the author reviewed the indications, the effects on anxiety and sleep disorders, the side effects, the drug-drug interactions, and the tapering strategies. Benzodiazepines were relatively safe and useful for the treatment of anxiety and sleep disorders. However, used clinically, benzodiazepines can induce many adverse effects (e. g. over-sedation, cognitive impairments, paradoxical effects, dependence and withdrawal symptoms, and so on). Currently available informations about their effects on the developing fetus is controversial. For this reason, pregnant women and nursing mother should be cautioned against the use of benzodiazepines. Drug-drug interactions have to be considered in combination treatments. For the tapering issues, gradual tapering was important to prevent the withdrawal symptoms. Especially, the tapering schedules have to be individualized for the each long-term benzodiapzepine users.

• 한국환경보건학회지
• /
• 제49권2호
• /
• pp.118-128
• /
• 2023

Background: The use of heated tobacco products (HTP) causes many adverse health effects. Although the use of HTP by adolescents is prevalent worldwide, research related to it is very limited. There is a considerable lack of research related to the current HTP use rather than ever-HTP use. In particular, research related to predictive factors for current HTP use in adolescents is scarce. Objectives: The purpose of this study was to analyze related characteristics according to the current use of HTP among South Korean adolescents. Methods: This was a cross-sectional study that used data from the Seventeenth Korean Youth Risk Behavior Web-based Survey (KYRBWS). A total of 54,848 students in 2021 were included in this study. Chi-square-test, multiple logistic regression analysis, and chi-square test for trend were used for analyzing related characteristics according to use of HTP. Results: Overall, 715 (1.3%) students responded as having used HTP during the last 30 days among the 54,848 students. It was found that residence type, subjective body type recognition, subjective health recognition, alcohol use, habitual drug experience, close friend current smoking, and conventional cigarette smoking were significantly associated characteristics with the current use of heated tobacco products. Comparing 'very thin recognition' with 'very fat recognition', the adjusted odds ratio (OR) was 1.93 (95% confidence interval [CI]: 1.29~2.87) for current use of HTP. Additionally, comparing 'very unhealthy recognition' with 'very healthy recognition', the aOR was 3.82 (95% CI: 2.40~6.07) for current use of HTP. Conclusions: Based on these results, residence type, subjective body type recognition, subjective health recognition, alcohol use, habitual drug experience, close friend current smoking, and conventional cigarette smoking were associated with significantly increased odds of current HTP use. Therefore, the results of this study can provide useful evidence about adolescent behaviors in predicting current HTP use.

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2001년도 International Symposium on Dietary and Medicinal Antimutgens and Anticarcinogens
• /
• pp.193-193
• /
• 2001

A murine local lymph node assay (LLNA) has been developed as an alternative to guinea pig models for contact sensitization potential. However, a disadvantage of the LLNA is the need for the use of radioactive material. In this study, we aimed to investigate the development of non-radio isotopic endpoint for LLNA using immunohistochemistry.(omitted)